Modern data of ibuprofen safety in pediatric patients
Summary. Modern data of safety of ibuprofen in pediatric patients as symptomatic antipyretic treatment is analyzed in the article. Questions of cardiovascular risks and risks of development and exacerbation of asthma and soft tissue infection are considered. Own experience of ibuprofen use in children and practical recommendations for ibuprofen dosing are given.
Key words: children, infectious diseases, antipyretic therapy, ibuprofen, Nurofen®.